Multidisciplinary guidelines: orally inhaled products

The European Medicines Agency's scientific guidelines on orally inhaled products help medicine developers prepare marketing authorisation applications for human medicines.

HumanAdvanced therapiesRegulatory and procedural guidanceInnovationResearch and developmentScientific guidelines

Finnish is available via eTranslation, the European Commission's machine translation service.

Translate to Finnish | Important information about machine translation

For a complete list of scientific guidelines currently open for consultation, see Public consultations.

Guidelines

Requirements for demonstrating therapeutic equivalence between orally inhaled products (OIP) for asthma and chronic obstructive pulmonary disease (COPD)

Questions and answers

Questions and answers on data requirements when transitioning to low global warming potential (LGWP) propellants in oral pressurised metered dose inhalers

Aiheet

Advanced therapies
Regulatory and procedural guidance
Innovation
Research and development
Scientific guidelines

Multidisciplinary guidelines: orally inhaled products

Guidelines

Questions and answers

Related content

Aiheet

Share this page